CLASS II ONGOING Device recall · Reported 9 Apr 2025 · FDA Enforcement Report

Pacific Hemostasis Thromboplastin-D Used recalled by Fisher Diagnostics

Fisher Diagnostics is recalling Pacific Hemostasis Thromboplastin-D Used in performing one-stage prothrombin time test, distributed in Pennsylvania. The recall was initiated on 6 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog No. 100357; UDI: 00845275000798665150270131100357; Lot No. 665150; Exp. Date 01/31/2027.
Quantity recalled1,699 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1503-2025
FDA event ID
96488
Recalling firm
Fisher Diagnostics, Middletown, VA
Classification
Class II
Status
Ongoing
Recall initiated
6 Mar 2025
FDA classified
31 Mar 2025
Reported
9 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

6 Mar 2025Recall initiated by company
31 Mar 2025Classified by FDA+25 days
9 Apr 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Pacific Hemostasis Thromboplastin-D, 10 ml. Used in performing one-stage prothrombin time test and factor assays.

Where it was distributed

US Distribution to: PA and OUS Foreign country of: United Arab Emirates.

Pennsylvania

Questions about this recall

Is Pacific Hemostasis Thromboplastin-D Used in performing one-stage prothrombin time test recalled?

Yes. Fisher Diagnostics recalled Pacific Hemostasis Thromboplastin-D Used in performing one-stage prothrombin time test on 6 Mar 2025. The recall is Class II and its status is Ongoing. Recall number Z-1503-2025.

Why was it recalled?

The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

Which lots are affected?

Catalog No. 100357; UDI: 00845275000798665150270131100357; Lot No. 665150; Exp. Date 01/31/2027.

Where was it sold?

US Distribution to: PA and OUS Foreign country of: United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fisher Diagnostics

All 4

Other Test Kits & Diagnostics recalls

All 2,656